HeyFlow, a Bristol-based femtech startup, receives £235k investment.
- The funding will be used to enhance their tech platform and employee insights product.
- Aer Venture Studios backs the firm, with directorial involvement in its future.
- Co-Founder Sophie Creese highlights the importance of reproductive health in the workplace.
- Statistics show significant reproductive health challenges faced by women year after year.
HeyFlow, a promising startup based in Bristol, has successfully secured an investment of £235,000 from Aer Venture Studios. This funding marks a significant milestone for the company as it aims to expand its efforts in addressing the challenges faced by women in the workplace. The company is primarily focused on promoting reproductive health inclusion and closing gender gaps, a mission they have pursued with notable early success.
The investment will be strategically used to bolster the development of HeyFlow’s technological infrastructure and refine their innovative employee insights product. This product is designed to reshape organisational behaviour, ensuring that businesses not only retain and promote female talent but also increase their profitability in the process. The efforts stand to create a more equitable and inclusive workplace environment.
Aer Venture Studios is playing a critical role in the future trajectory of HeyFlow, with Directors Geoff Wells and Tom Harber actively involved in guiding the company. Geoff Wells will join the board, reflecting Aer Venture Studios’ strong commitment to the startup. This backing sends a resolute message supporting the potential and innovation inherent in women-led enterprises.
Sophie Creese, a Co-Founder of HeyFlow, emphasised the validation and encouragement that come with securing such pivotal funding. She stated, “A testament to our early success and powerful validation of our mission to champion reproductive health inclusion and close workplace gender gaps;” this kind of support is crucial in a landscape where women-led startups often receive disproportionately low levels of investment.
The need for HeyFlow’s mission is underscored by compelling statistics: 31% of women experience severe reproductive health symptoms yearly, with 85% facing at least four reproductive health conditions. Additionally, the economic disparity becomes evident with mothers facing a 60% drop in earnings following their first child, contrasting sharply with their male counterparts.
HeyFlow’s recent investment exemplifies a growing recognition of the critical need for female-focused workplace health solutions.
